"Progestins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY.
| Descriptor ID |
D011372
|
| MeSH Number(s) |
D27.505.696.399.472.858
|
| Concept/Terms |
Progestins- Progestins
- Progestagens
- Progestational Hormones
- Progestogens
- Gestagen
- Progestational Compounds
- Progestagenic Agents
- Gestagenic Agents
- Progestin
- Gestagens
- Progestational Agents
Progestin Effect- Progestin Effect
- Effect, Progestin
- Progestogen Effect
- Effect, Progestogen
- Gestagenic Effects
- Effects, Gestagenic
- Gestagen Effect
- Effect, Gestagen
- Gestagen Effects
- Effects, Gestagen
- Gestagenic Effect
- Effect, Gestagenic
- Progestin Effects
- Effects, Progestin
- Progestogen Effects
- Effects, Progestogen
|
Below are MeSH descriptors whose meaning is more general than "Progestins".
Below are MeSH descriptors whose meaning is more specific than "Progestins".
This graph shows the total number of publications written about "Progestins" by people in this website by year, and whether "Progestins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2009 | 0 | 1 | 1 |
| 2010 | 2 | 0 | 2 |
| 2014 | 0 | 1 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Progestins" by people in Profiles.
-
Effects of depot medroxyprogesterone acetate, the copper IUD and the levonorgestrel implant on testosterone, sex hormone binding globulin and free testosterone levels: ancillary study of the ECHO randomized clinical trial. BMC Womens Health. 2024 Mar 08; 24(1):167.
-
Misreporting contraceptive use and the association of peak study progestin levels with weight and BMI among women randomized to the progestin-only injectable contraceptives DMPA-IM and NET-EN. PLoS One. 2023; 18(12):e0295959.
-
Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial. Reprod Health. 2021 Sep 29; 18(1):192.
-
Changes to the World Health Organization guideline on hormonal contraceptive eligibility for women at high risk of HIV: South African perspective and response. S Afr Med J. 2018 Jul 25; 108(8):629-631.
-
Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial. Reprod Health. 2016 Apr 18; 13:42.
-
Hormonal contraception for women exposed to HIV infection. Cochrane Database Syst Rev. 2014 May 20; (5):CD009741.
-
Progestogen-only injectable hormonal contraceptive use should be considered in analysis of studies addressing the loss of bone mineral density in HIV-positive women. J Acquir Immune Defic Syndr. 2010 Aug; 54(4):e5.
-
Copper containing intra-uterine devices versus depot progestogens for contraception. Cochrane Database Syst Rev. 2010 Jun 16; (6):CD007043.
-
A pilot investigation of load-carrying on the head and bone mineral density in premenopausal, black African women. J Bone Miner Metab. 2010 Mar; 28(2):185-90.